Scancell Holdings plc (LON:SCLP) Insider Martin Diggle Buys 4,400,000 Shares of Stock

Scancell Holdings plc (LON:SCLP) insider Martin Diggle acquired 4,400,000 shares of the stock in a transaction on Friday, August 1st. The shares were purchased at an average price of GBX 10 ($0.13) per share, with a total value of £440,000 ($584,795.32).

Martin Diggle also recently made the following trade(s):

• On Tuesday, May 20th, Martin Diggle acquired 44,944 shares of Scancell stock. The shares were purchased at an average price of GBX 9 ($0.12) per share, with a total value of £4,044.96 ($5,376.08).

Scancell Stock Up 4.8%

Shares of SCLP opened at GBX 11 ($0.15) on Tuesday. The firm has a 50 day simple moving average of GBX 9.93 and a two-hundred day simple moving average of GBX 9.44. The company has a market cap of £113.93 million, a P/E ratio of -16.86 and a beta of 0.35. Scancell Holdings plc has a one year low of GBX 7.26 ($0.10) and a one year high of GBX 19.75 ($0.26). The company has a debt-to-equity ratio of -566.79, a current ratio of 3.42 and a quick ratio of 13.01.

About Scancell

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.